Peter P. Pfreundschuh
2015 - Immunomedics
In 2015, Peter P. Pfreundschuh earned a total compensation of $604K as Former VP Finance and Chief Financial Officer at Immunomedics, a 7% increase compared to previous year.
Compensation breakdown
| Option Awards | $52,499 |
|---|---|
| Salary | $300,000 |
| Stock Awards | $248,220 |
| Other | $3,250 |
| Total | $603,969 |
Pfreundschuh received $300K in salary, accounting for 50% of the total pay in 2015.
Pfreundschuh also received $52.5K in option awards, $248.2K in stock awards and $3.3K in other compensation.
Rankings
In 2015, Peter P. Pfreundschuh's compensation ranked 10,119th out of 13,638 executives tracked by ExecPay. In other words, Pfreundschuh earned more than 25.8% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 10,119 out of 13,638 | 26th |
Division Manufacturing | 3,859 out of 5,190 | 26th |
Major group Chemicals And Allied Products | 1,415 out of 1,854 | 24th |
Industry group Drugs | 1,161 out of 1,528 | 24th |
Industry In Vitro and In Vivo Diagnostic Substances | 48 out of 76 | 37th |
Source: SEC filing on November 2, 2016.
Pfreundschuh's colleagues
We found two more compensation records of executives who worked with Peter P. Pfreundschuh at Immunomedics in 2015.
News
Korro Bio CEO David Lucchino's 2020 pay falls 29% to $5.2M
April 29, 2021
UroGen Pharma Ltd. CEO Elizabeth Barrett's 2020 pay falls 90% to $2.5M
April 28, 2021
UroGen Pharma Ltd. CEO Elizabeth Barrett receives $26M in 2019
April 29, 2020
UroGen Pharma Ltd. CEO Ron Bentsur's 2018 pay jumps 202% to $6M
April 26, 2019